Pieris

Talk by Thibaut Angevin, PhD, Pieris Pharmaceuticals GmbH

Nov. 21 – 12:15 : “Establishment of a CHO Transient Expression Platform for Bispecific Fusion Protein Developability Assessment”

Pieris' website